Aclarion Appoints Dan Isherwood as UK Commercial Director
Aclarion, Inc. (NASDAQ: ACON, ACONW) is thrilled to announce the recent appointment of Dan Isherwood as the new UK Commercial Director. This marks Aclarion's entry into an enhanced commercial phase as Dan brings a wealth of experience and expertise, particularly in the HealthTech sector, focusing on musculoskeletal imaging and spinal treatments.
Significant Growth in the UK Market
The UK market is witnessing incredible momentum as Aclarion's initial market for the Nociscan service. With private insurers beginning to cover the Nociscan procedure, Aclarion has established its foothold, leading to heightened access for patients. Currently, three of the four leading private insurers in the UK have begun to reimburse for Nociscan, directly benefiting over 5.2 million individuals.
The Role of Nociscan
Nociscan is an innovative healthcare solution allowing physicians to noninvasively identify the source of chronic low back pain through advanced imaging. Aclarion positions Nociscan as the first evidence-supported platform that leverages biomarkers and advanced signal processing techniques to dissect the chemical and biological signals associated with painful and non-painful lumbar discs.
A Vision for the Future
Brent Ness, CEO of Aclarion, expressed optimism regarding Dan’s appointment, stating, “Dan’s hire represents a significant commercial milestone for the Company. With the barriers removed for so many patients, combined with our partnership with The London Clinic, we are eager to build on the strong early growth in the UK market.”
Dan Isherwood's Expertise
Dan Isherwood comes with an impressive track record in advanced imaging technology and spine health solutions. His prior roles at major industry players like J&J MedTech and NuVasive have equipped him with unique insights into driving the adoption of clinical technologies. His previous hands-on experience as a healthcare provider adds a patient-focused perspective to Aclarion's commercial strategy, reinforcing the company’s commitment to improving patient outcomes.
Addressing a Major Health Challenge
Chronic low back pain affects approximately 266 million people globally, making it one of the most prevalent health challenges faced today. Nociscan serves as a groundbreaking tool for physicians, providing them with vital information to make informed clinical decisions about managing their patients' care effectively.
The Nociscan Advantage
The Nociscan solution helps physicians distinguish between painful and non-painful discs in the lumbar spine, thereby improving surgical outcomes. By using proprietary algorithms that quantify biomarkers linked to disc pain, clinicians can harness valuable insights, enabling optimized treatment plans and personalized patient care.
Contact and Engagement
To learn more about where to find Nociscan services, individuals are encouraged to visit Aclarion’s website. For inquiries, the company welcomes communication via email: info@aclarion.com.
About Aclarion, Inc.
Aclarion, Inc. leverages cutting-edge technologies to transform chronic low back pain diagnosis and treatment. Their unique SaaS platform, Nociscan, showcases their commitment to optimizing patient care through innovative diagnostic solutions. By harnessing the power of Magnetic Resonance Spectroscopy (MRS) and proprietary algorithms, Aclarion is positioned to redefine the future of back pain management.
Frequently Asked Questions
What is Nociscan?
Nociscan is a revolutionary SaaS platform developed by Aclarion to help physicians identify painful lumbar discs through biomarkers and advanced imaging techniques.
Who is Dan Isherwood?
Dan Isherwood is Aclarion's newly appointed UK Commercial Director, bringing extensive experience in imaging and spine care technology.
How does Nociscan help patients?
Nociscan provides detailed insights into low back pain, allowing healthcare providers to make informed decisions about patient management and treatment.
How many patients are affected by chronic low back pain?
Approximately 266 million people worldwide suffer from chronic low back pain, highlighting the need for effective diagnostic and treatment options.
What does Aclarion focus on?
Aclarion focuses on innovative healthcare solutions, with a primary emphasis on chronic low back pain through their Nociscan platform, employing advanced imaging and artificial intelligence.
